Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb 20;14(1):17.
doi: 10.1186/1532-429X-14-17.

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance

Affiliations
Review

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance

Radwa A Noureldin et al. J Cardiovasc Magn Reson. .

Abstract

Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the heart. HCM is characterized by a wide range of clinical expression, ranging from asymptomatic mutation carriers to sudden cardiac death as the first manifestation of the disease. Over 1000 mutations have been identified, classically in genes encoding sarcomeric proteins. Noninvasive imaging is central to the diagnosis of HCM and cardiovascular magnetic resonance (CMR) is increasingly used to characterize morphologic, functional and tissue abnormalities associated with HCM. The purpose of this review is to provide an overview of the clinical, pathological and imaging features relevant to understanding the diagnosis of HCM. The early and overt phenotypic expression of disease that may be identified by CMR is reviewed. Diastolic dysfunction may be an early marker of the disease, present in mutation carriers prior to the development of left ventricular hypertrophy (LVH). Late gadolinium enhancement by CMR is present in approximately 60% of HCM patients with LVH and may provide novel information regarding risk stratification in HCM. It is likely that integrating genetic advances with enhanced phenotypic characterization of HCM with novel CMR techniques will importantly improve our understanding of this complex disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Left ventricular patterns in HCM, each drawing is accompanied by its corresponding image, (A, a) normal LV, (B, b) sigmoid septum showing SAM of mitral valve (white arrow), (C, c) reversed septal contour, note that there is no signs of LVOT, (D, d) mid ventricular hypertrophy, (E, e) Apical HCM, (F, f) symmetric HCM.
Figure 2
Figure 2
Late gadolinium enhancement patterns involving the anterior and posterior RV insertion points, as shown; the interventricular septum is involved, particularly the anteroseptal basal segment (three arrow heads).
Figure 3
Figure 3
Patchy mid wall, variable sized foci of hyperenhancement in a non-coronary distribution, involving mainly the hypertrophied parts (arrow heads). Right ventricle is also hypertrophied (large arrows).

Similar articles

Cited by

References

    1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320. doi: 10.1001/jama.287.10.1308. - DOI - PubMed
    1. O'Hanlon R, Pennell DJ. Cardiovascular magnetic resonance in the evaluation of hypertrophic and infiltrative cardiomyopathies. Heart Fail Clin. 2009;5:369–387. doi: 10.1016/j.hfc.2009.02.003. vi. - DOI - PubMed
    1. Judge DP, Johnson NM. Genetic evaluation of familial cardiomyopathy. J Cardiovasc Transl Res. 2008;1:144–154. doi: 10.1007/s12265-008-9025-1. - DOI - PubMed
    1. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour JB. et al.Penetrance of familial hypertrophic cardiomyopathy. Genet Couns. 1997;8:107–114. - PubMed
    1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816. doi: 10.1161/CIRCULATIONAHA.106.174287. - DOI - PubMed

Publication types

MeSH terms